Coherus Biosciences | Passivo Circulante



Current Liabilities Alterar Data
AbbVie USD 38.75B 4.31B 2024-12
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
ALKERMES USD 443.73M 21.47M 2025-03
Alnylam Pharmaceuticals USD 1.08B 110.65M 2025-03
Amarin USD 162.41M 17.54M 2025-03
Amgen USD 23.01B 91M 2025-03
Baxter International USD 6.51B 311M 2024-12
Biogen USD 5.3B 231.4M 2025-03
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Fujifilm JPY 1.13T 28.37B 2025-03
Gilead Sciences USD 12B 279M 2024-12
Ironwood Pharmaceuticals USD 39.15M 10.24M 2024-12
Merck USD 25.17B 3.25B 2025-03
Myriad Genetics USD 151.1M 13M 2025-03
Pacira USD 314.73M 4.81M 2025-03
Perrigo USD 1.07B 29.6M 2025-03
Pfizer USD 36.45B 6.54B 2025-03
PTC Therapeutics USD 595.39M 14.41M 2025-03
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
Teva Pharmaceutical Industries USD 11.16B 1.64B 2025-03
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12
Xencor USD 88.44M 1M 2025-03
Zoetis USD 3.38B 27M 2025-03



Coherus Biosciences Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.